SUMMARY In order to examine the relation of Epstein-Barry virus (EBV) infection to chronic arthritis in children antibodies to EB virus capsid antigen (EBVCA) and rheumatoid arthritis nuclear antigen (RANA) were analysed in sera from 133 patients classified as juvenile rheumatoid arthritis (JRA) or pauciarticular, polyarticular, or systemic juvenile chronic arthritis. Except for an increased frequency in the systemic subgroup, the prevalence of antibodies to EBVCA and titres of anti-RANA antibodies was similar in patients and controls. These data do not support an aetiological role for EBV in chronic arthritis in children, including JRA, and suggest that the mechanisms which may account for the higher titres of anti-RANA antibodies in adult RA do not occur in children.
The possibility of an association between rheumatoid arthritis (RA) and the Epstein-Barr virus (EBV) excites interest for two reasons: firstly, as identifying a possible aetiological agent and secondly, because of evidence of an abnormal responsiveness to the virus. It is now clear that EBV cannot be the sole aetiological agent, since several studiesl- 3 have reported RA patients without antibodies to EB viral capsid antigens (VCAs) which are regarded as a reliable marker of previous EBV infection. Evidence for an abnormal response to the virus is often stated to be the finding of higher titres of antibodies to EBVCA, EB nuclear antigen (EBNA), and early antigen (EA) in sera from RA patients, though these studies disagree on the specificity of the antibodies that are raised. 
STATISTICS
The prevalence of antibodies in each of the groups was compared with each other and with a similar historical control group described in a previous study.9 Significance was determined by the x2 test. Anti-RANA antibodies were detected in 17 out of 73 patients with JCA (23%) and six out of 20 controls (30%) ( Table 3) . Twenty nine patients were VCA positive and of these 15 (52%) had anti-RANA antibodies, similar to the findings for the adult controls where, among VCA positive sera, 63% were anti-RANA positive. The titres were also 
